The Valley Fever Institute at Kern Medical (VFI) joined forces with patients, physicians, researchers, community organizations, and other stakeholders throughout California to raise awareness of the threat posed by Antimicrobial Resistance (AMR).

To support the development of new antimicrobial treatments, Congress must create strong financial incentives for investing in new treatments paired with policies that address stewardship and surveillance, stabilize the current market through payment and reimbursement reforms, and address barriers that prevent patients from getting access to the appropriate medicines.

The Valley Fever Institute continues to work with California’s Senators and Representatives to address the growing impact of Valley Fever and Antimicrobial Resistance on our State.  We look forward to continued bipartisan efforts to create new diagnostics, treatments and vaccines.